CARM icon

Carisma Therapeutics
CARM

Overview Fund Activity

22 hedge funds and large institutions have $1.93M invested in Carisma Therapeutics in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 7 closing their positions.

Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MERSOM
1
Municipal Employees' Retirement System of Michigan
Michigan
$382K
2
VF
2
Virtu Financial
New York
$61K
3
Citadel Advisors
3
Citadel Advisors
Florida
$36K
4
Citigroup
4
Citigroup
New York
$1K

Top Sellers

1
SIM
1
Spark Investment Management
New York
$0
2
ARTA
2
A.R.T. Advisors
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$291K
4
TSS
4
Two Sigma Securities
New York
$0
5
OAM
5
Oxford Asset Management
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of Montreal
26
Bank of Montreal
Ontario, Canada
– -$8K -250 Closed
1
2